PatchSiren

PatchSiren cyber security CVE debrief

CVE-2026-100529 OpenClaw CVE debrief

OpenClaw versions before 2026.8.1 contain an authorization scope widening vulnerability in file-transfer allow-always approvals. This allows attackers to reuse standing grants for unreviewed paths by exploiting glob metacharacter interpretation and node display name reuse, potentially accessing sibling paths or different nodes beyond the operator's original approval scope.

Vendor
OpenClaw
Product
Unknown
CVSS
HIGH 7.4
CISA KEV
Not listed in stored evidence
Original CVE published
2026-09-26
Original CVE updated
2026-09-26
Advisory published
2026-09-26
Advisory updated
2026-09-26

Who should care

Defenders responsible for OpenClaw deployments should assess exposure and prioritize verification and remediation. This includes reviewing OpenClaw versions, restricting access to sensitive paths, and monitoring for suspicious activity. Security teams should track exceptions, retest remediated assets, and close the item only after evidence is documented. OpenClaw operators and security teams must collaborate to ensure prompt remediation and minimize the风险.

Why it matters

Defenders should care about CVE-2026-100529 because it allows attackers to potentially access unauthorized paths in OpenClaw versions before 2026.8.1, requiring verification and remediation.

  • Potential unauthorized access to sensitive paths
  • Need to verify OpenClaw version and restrict access
  • Possible exploitation of glob metacharacter interpretation

Technical summary

The vulnerability in OpenClaw versions before 2026.8.1 allows attackers to reuse standing grants for unreviewed paths by exploiting glob metacharacter interpretation and node display name reuse. This could potentially allow access to sibling paths or different nodes beyond the operator's original approval scope. Affected deployments should be verified and remediated promptly to prevent unauthorized access. OpenClaw operators must review and restrict access to sensitive paths, and monitor for suspicious activity. The CVE record provides additional details on the vulnerability.

Defensive priority

Defenders should prioritize verifying OpenClaw versions and restricting access to sensitive paths.

Recommended defensive actions

  • Verify OpenClaw version and upgrade to 2026.8.1 or later
  • Restrict access to sensitive paths and monitor for suspicious activity
  • Review and update file-transfer allow-always approvals
  • Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up
  • Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance
  • Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed
  • Check relevant monitoring, detection, and logs for exposed assets that need extra review

Evidence notes

The CVE record and NVD entry provide details on the vulnerability. Additional information on affected versions and remediation is needed. OpenClaw versions before 2026.8.1 are affected. Defenders should verify OpenClaw deployments and review file-transfer allow-always approvals. Evidence limits suggest vulnerability scope may be broader than initially reported.

Sources and references

Verified primary and authoritative sources

  • CVE-2026-100529 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2026-100529

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2026-100529 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2026-100529

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.